{"title":"口服抗真菌药酮康唑治疗生殖器念珠菌病。","authors":"A Silva-Cruz, V Duarte","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Fifty-three women with clinical evidence of vaginal candidosis confirmed by culture were entered into an open study. Patients received 400 mg ketoconazole once daily for 5 days. At 2 weeks post-treatment, 49 (92.5%) showed clinical and microbiological remission. The remaining 4 patients received 400 mg ketoconazole once daily for a further 21 days, along with a 400 mg 5-day course for their sexual partners. On completion of this second course of treatment, 3 of these patients were cured. Apart from some mild nausea, no side-effects were reported or observed.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 7","pages":"411-5"},"PeriodicalIF":0.0000,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The management of genital candidosis with an oral antimycotic agent, ketoconazole.\",\"authors\":\"A Silva-Cruz, V Duarte\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Fifty-three women with clinical evidence of vaginal candidosis confirmed by culture were entered into an open study. Patients received 400 mg ketoconazole once daily for 5 days. At 2 weeks post-treatment, 49 (92.5%) showed clinical and microbiological remission. The remaining 4 patients received 400 mg ketoconazole once daily for a further 21 days, along with a 400 mg 5-day course for their sexual partners. On completion of this second course of treatment, 3 of these patients were cured. Apart from some mild nausea, no side-effects were reported or observed.</p>\",\"PeriodicalId\":19862,\"journal\":{\"name\":\"Pharmatherapeutica\",\"volume\":\"4 7\",\"pages\":\"411-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1986-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmatherapeutica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmatherapeutica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The management of genital candidosis with an oral antimycotic agent, ketoconazole.
Fifty-three women with clinical evidence of vaginal candidosis confirmed by culture were entered into an open study. Patients received 400 mg ketoconazole once daily for 5 days. At 2 weeks post-treatment, 49 (92.5%) showed clinical and microbiological remission. The remaining 4 patients received 400 mg ketoconazole once daily for a further 21 days, along with a 400 mg 5-day course for their sexual partners. On completion of this second course of treatment, 3 of these patients were cured. Apart from some mild nausea, no side-effects were reported or observed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
